GKHT Medical Technology Co., Ltd. Class A

GKHT Medical Technology Co., Ltd. Class A

SSZSE:301370
7.79
CNY
-0.11
(-1.39%)
-0.02EPS
339.86P/E
4.11BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
2.92
6.48
10.32
6.85
10.5
11.65
12.32
14.69
15.78
17.51
15.74
14.35
14.22
Basic EPS, GAAP
0.09
0.1
0.37
0.22
0.27
0.41
0.37
0.38
0.31
0.36
0.28
0.14
0.03
Free Cash Flow per Basic Share
-0.38
-1.85
-1.72
-0.85
-1.58
-1.57
-0.74
0.37
0.53
1.32
1.3
1.33
- -
Dividend per Share
0.06
0.09
0.23
0.14
0.2
0.39
0.3
0.32
0.3
0.23
0.24
0.14
0.26
Book Value per Share
0.44
0.57
1.89
2.28
2.91
2.59
2.96
3.34
3.64
5.21
5.26
5.33
5.23
Tangible Book Value per Share
0.44
0.56
1.87
2.18
2.77
2.36
2.72
3.1
3.38
4.97
4.98
5.01
4.89
Basic Weighted Avg Shares
150
150
151
338
346
364
395
398
403
427
467
487
454
Sales/Revenue/Turnover
438
972
1,564
2,316
3,637
4,246
4,862
5,847
6,360
7,483
7,346
6,987
6,453
Operating Margin (%)
5.28
4
6.4
6.26
5.94
8
7.99
7.17
5.82
4.52
3.43
3.04
2.43
Depreciation Expense
- -
1
1
2
3
9
19
71
98
103
112
97
- -
Net Income, GAAP
14
15
56
74
93
149
146
151
125
154
131
68
12
Effective Tax Rate (%)
25.64
35.74
28.11
28.08
27.71
28.29
26.91
25.64
27.43
27.69
19.66
29.95
132.56
Profit Margin (%)
3.19
1.59
3.58
3.21
2.57
3.52
3
2.59
1.96
2.06
1.78
0.98
0.18
Working Capital
61
77
270
319
430
975
1,085
1,115
1,105
1,921
1,960
1,866
1,734
LT Debt
- -
- -
- -
- -
- -
- -
46
29
178
146
178
158
158
Total Equity
67
86
283
348
487
1,124
1,291
1,464
1,557
2,551
2,563
2,551
2,465
Return on Invested Capital (%)
- -
8.59
10.4
7.73
6.06
6.75
5.26
5.03
3.6
4.29
3.82
1.64
- -
Return on Capital (%)
- -
8.73
11.01
11.34
21.24
26.04
23.65
13.53
6.86
4.9
3.99
2.49
- -
Return on Common Equity (%)
- -
20.24
30.41
23.79
24.03
20.3
13.16
12.02
8.96
7.88
5.3
2.73
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
1,195
1,265
1,343
LT Borrowings
154
117
117
LT Finance Leases
46
44
42
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
471
471
471
Market Capitalization
4,890
3,807
4,113

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
5,310
5,361
5,331
Cash, Cash Equivalents & STI
641
619
573
Accounts Receivable, Net
1,326
1,234
1,092
Inventories
2,545
2,701
2,735
Total Current Liabilities
3,413
3,595
3,598
Payables & Accruals
- -
- -
- -
ST Debt
1,195
1,265
1,343
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
52.29%
16.71%
-0.46%
Free Cash Flow
12.42%
14.77%
6.55%
Net Income, GAAP
32.6%
-10.72%
-47.84%
Sales/Revenue/Turnover
23.73%
8%
-4.89%
Total Cash Common Dividend
28.74%
-8.66%
-39.17%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,714
1,945
1,821
1,867
7,346
2025
1,738
1,940
- -
1,634
6,987
2026
1,568
1,597
1,655
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.08
0.08
0.07
0.28
2025
-0.02
0.13
- -
- -
0.14
2026
- -
0.02
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.05
0.13
0.02
0.24
2025
0.02
0.12
- -
-0.01
0.14
2026
0.03
0.14
0.1
- -
- -

Company Description

CEO
Wei Xiao
Full Time Employees
873
Sector
Distribution services
Industry
Medical distributors
Address
Beijing China
IPO Date
Jul 12, 2023
Website
gkht.com
Business
GKHT Medical Technology Co., Ltd. is a China-based integrated medical device supply chain service provider and distributor specializing in high-value medical consumables and healthcare logistics solutions. Founded in 2013 and headquartered in Beijing, China, the company operates as a member enterprise of Oriental Scientific Instrument Holdings under the Chinese Academy of Sciences Holding Co., Ltd. (CAS Holdings). The company engages primarily in the authorized distribution and direct sales of medical devices, delivering end-to-end digital supply chain services that connect international and domestic medical equipment manufacturers with healthcare institutions, clinical departments, and regional distributors across mainland China. The company offers a comprehensive range of medical products and hospital supply chain services. Its product distribution portfolio comprises vascular intervention consumables, including coronary stents, balloon dilatation catheters, guidewires, and peripheral vascular intervention devices; orthopedic implants and surgical materials, including trauma, spine, and joint replacement systems; neurosurgical consumables; non-vascular interventional therapy products; electrophysiology devices; in vitro diagnostic (IVD) reagents and analyzers; and general surgery and dental materials, representing leading multinational brands such as Boston Scientific, Medtronic, Abbott Laboratories, and Johnson & Johnson. Its service offerings include hospital Supply, Processing, and Distribution (SPD) operational management services, which deliver intelligent hospital warehouse management, point-of-use inventory control, RFID and barcode traceability, and automated replenishment for operating rooms; third-party medical logistics (3PL), temperature-monitored cold chain storage, and multi-tier regional warehousing; channel logistics information management; and proprietary Software-as-a-Service (SaaS) healthcare supply chain platforms. In recent developments, GKHT Medical Technology Co., Ltd. has expanded its nationwide operational presence by establishing regional wholly-owned subsidiaries in Henan, Hebei, Liaoning, and Hainan provinces. The company enhanced its cross-border medical logistics and warehousing infrastructure through its subsidiary Guoke Hengxiang (Tianjin) Medical Technology Co., Ltd., which commenced bonded logistics warehouse operations in Tianjin. To address the deepening effects of national volume-based procurement (VBP) policies and strengthen end-hospital service integration, the company has actively scaled its digital SPD management service contracts across major tertiary Class 3A hospitals throughout China and advanced corporate equity consolidations, including the acquisition of minority interests in key operating subsidiaries and equity integration in digital healthcare logistics platforms such as Fujian Youzhilian Medical Technology Co., Ltd.